Structures of monomeric and oligomeric forms of the Toxoplasma gondii perforin-like protein 1 par Ni, T, Williams, S, Rezelj, S, Anderluh, G, Harlos, K, Stansfeld, P, Gilbert, R

Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial par Jelena Tica, Veronica V. Rezelj, Benoit Baron, Vitalija van Paassen, Javier Zaidman, Lee Fairlie, Gert Scheper, Mathieu Le Gars, Frank Struyf, Macaya Douoguih, Javier Ruiz-Guiñazú

Accéder au texte intégral

Safety and Humoral Immunogenicity of Different Dose Levels of Ad26.COV2.S as a 2-Dose Regimen in COVID-19 Vaccine-Naïve Healthy Adults: A Phase 3 Randomized Clinical Trial par Veronica V. Rezelj, Fred Paddenburg, Marie Enajite Diegbe, Julius Nangosyah, Emil C. Reisinger, Weihong Hu, Carla Truyers, Gert Scheper, Mathieu Le Gars, Jenny Hendriks, Frank Struyf, Macaya Douoguih, Hanneke Schuitemaker, Javier Ruiz-Guiñazú

Accéder au texte intégral

The Biodistribution of the Spike Protein after Ad26.COV2.S Vaccination Is Unlikely to Play a Role in Vaccine-Induced Immune Thrombotic Thrombocytopenia par Sonia Marquez-Martinez, Selina Khan, Joan van der Lubbe, Laura Solforosi, Lea M. M. Costes, Ying Choi, Satish Boedhoe, Mieke Verslegers, Marjolein van Heerden, Wendy Roosen, Sandra De Jonghe, Hendy Kristyanto, Veronica Rezelj, Jenny Hendriks, Jan Serroyen, Jeroen Tolboom, Frank Wegmann, Roland C. Zahn

Accéder au texte intégral

Full genome sequence and sfRNA interferon antagonist activity of Zika virus from Recife, Brazil par Donald, C, Brennan, B, Cumberworth, S, Rezelj, V, Clark, J, Cordeiro, M, Freitas de Oliveira França, R, Pena, L, Wilkie, G, Da Silva Filipe, A, Davis, C, Hughes, J, Varjak, M, Selinger, M, Zuvanov, L, Owsianka, A, Patel, A, McLauchlan, J, Lindenbach, B, Fall, G, Sall, A, Biek, R, Rehwinkel, J, Schnettler, E, Kohl, A